The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
117344114 11734411 4 F 20160914 20151113 20160926 EXP PHEH2015US023414 NOVARTIS 0.00 M Y 0.00000 20160926 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
117344114 11734411 1 PS ZOFRAN ONDANSETRON HYDROCHLORIDE 1 Transplacental D 20007
117344114 11734411 2 SS ONDANSETRON HYDROCHLORIDE. ONDANSETRON HYDROCHLORIDE 1 Transplacental MOTHER'S DOSE: 04 MG, TWICE DAILY (BID) AND 01 TABLET (DF), Q6H D 0 TABLET

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
117344114 11734411 1 Foetal exposure during pregnancy
117344114 11734411 2 Foetal exposure during pregnancy

Outcome of event

Event ID CASEID OUTC COD
117344114 11734411 CA
117344114 11734411 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
117344114 11734411 Abdominal pain
117344114 11734411 Adenoiditis
117344114 11734411 Anhedonia
117344114 11734411 Anxiety
117344114 11734411 Cleft palate
117344114 11734411 Congenital anomaly
117344114 11734411 Deafness
117344114 11734411 Deformity
117344114 11734411 Dermatitis
117344114 11734411 Dermatitis contact
117344114 11734411 Developmental delay
117344114 11734411 Ear infection
117344114 11734411 Emotional distress
117344114 11734411 Feeding disorder
117344114 11734411 Foetal exposure during pregnancy
117344114 11734411 Gastrointestinal inflammation
117344114 11734411 Gastrooesophageal reflux disease
117344114 11734411 Influenza
117344114 11734411 Injury
117344114 11734411 Lactose intolerance
117344114 11734411 Otitis media chronic
117344114 11734411 Pain
117344114 11734411 Patent ductus arteriosus
117344114 11734411 Pharyngitis
117344114 11734411 Poor weight gain neonatal
117344114 11734411 Post procedural complication
117344114 11734411 Pyrexia
117344114 11734411 Respiratory disorder
117344114 11734411 Speech disorder
117344114 11734411 Tonsillitis
117344114 11734411 Upper respiratory tract infection
117344114 11734411 Vomiting

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found